logo-loader
viewAbbvie

Abbvie advances as it raises full year outlook

Earnings per share (EPS) for the three months came in at US$1.41 a share, beating consensus estimates of US$1.39 each.

1509111370_shutterstock_168702206.jpg
Abbve's third quarter surpassed expectations

Shares in New York listed biopharma Abbvie Inc (NYSE:ABBV) rose 2.28% to US$91.60 as its third quarter earnings beat estimates.

Earnings per share (EPS) for the three months came in at US$1.41 a share, beating consensus estimates of US$1.39 each.

It also raised its full year outlook for EPS in the range of between US$5.53 and US$5.55 a share compared to between US$5.44 and US$5.54 previously.

The group’s best known drug is the autoimmune drug Humira, which is approved for various conditions including arthritis and Crohn's disease.

It is a major contributor to revenues, which came in at US$7 billion, in line with consensus.

Humira sales came in at $4.7 billion, up 14.8% year over year, excluding the impact of currency.

Quick facts: Abbvie

Price: 78.56 USD

NYSE:ABBV
Market: NYSE
Market Cap: $116.01 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Nano One remains well funded adding another 250,000 thousand...

Nano One (CVE: NNO- OTC: NNOMF) CEO Dan Blondal joined Steve Darling from Proactive Vancouver to discuss how the company is dealing with the slowdown from COVID-19. Blondal has very positive news on that front. Blondal also told Proactive about a new very interesting development from the giant...

1 hour, 5 minutes ago

RNS

Form 8.3 - [Abbvie. Inc]

5 hours, 51 minutes ago

Norges Bank - Form 8.3 - AbbVie Inc

8 hours, 46 minutes ago

Form 8.3 - AbbVie Inc.

10 hours, 37 minutes ago

Form 8.3 - [Abbvie. Inc]

1 day, 7 hours ago

Form 8.3 - AbbVie Inc.

1 day, 10 hours ago

Form 8.3 - [Abbvie. Inc]

2 days, 4 hours ago

2 min read